Delivery Order SPE2DX22D0029-SPE2D826F08EP
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,317.72 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 8, 2025, with an ultimate completion date of December 9, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor vehicle running through December 2026. The delivery order represents a...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $174,043.94 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 2, 2025, with completion targeted for December 3, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and medical supply provider for federal...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $15,354.00 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order will be performed at the contractor's corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $38,190.96 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $39,468.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with completion due by December 2, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The award was made through...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,368.70 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,587.44 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999.99 million ceiling value extending through December...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $369,718.44 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,040.12 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order represents a non-competitive award to the prime contractor at their Conshohocken, Pennsylvania location. As a child contract under a larger vehicle, this delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $6,545.30 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 potential value through December 2026. The delivery...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F08EPDelivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $171,685.92 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order represents a non-competitive award to the prime contractor and is performed at the company's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company supplies a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order represents one of numerous firm fixed-price transactions the contractor fulfills under its DLA prime contract, demonstrating the company's capability to meet federal procurement requirements and support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and comprehensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $171.7k | 12/2/25 |